Lanreotide depot/autogel in neuroendocrine tumors: subgroup analyses from the CLARINET study.

Lanreotide depot/autogel in neuroendocrine tumors: subgroup analyses from the CLARINET study. Clin Adv Hematol Oncol. 2015 Jun;13(6 Suppl 7):6-8 Authors: Phan AT PMID: 26431403 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research